• RG108: DNA Methyltransferase Inhibitor for Epigenetic Modula

  2026-05-07

  RG108 stands out as a potent, non-cytotoxic DNA methyltransferase inhibitor, enabling precise epigenetic gene regulation in cancer and stem cell research. This guide distills optimized workflows, troubleshooting insights, and advanced applications to maximize RG108’s impact in demethylation assays and tumor suppressor gene reactivation.

• Early Pheromone Sensing Alters Neurodevelopment in C. elegan

  2026-05-06

  Peng et al. (2023) unravel how early-life pheromone perception in C. elegans triggers neurodevelopmental rewiring and accelerates neurodegeneration via integrated chemosensory and insulin-like signaling, impacting proteostasis. This research highlights environmental modulation of neurodegeneration and informs model selection for environmental and genetic neurobiology studies.

• Foxp1 Suppresses EndMT and Valvular Calcification in CKD Mod

  2026-05-06

  This paper demonstrates that endothelial Foxp1 overexpression inhibits Notch pathway-driven endothelial-to-mesenchymal transition (EndMT), leading to reduced valvular calcification in chronic kidney disease (CKD) models. These findings clarify regulatory nodes in the Jagged-1/Notch pathway and highlight Foxp1 as a crucial modulator of cardiovascular complications in CKD.

• Vorinostat (SAHA, MK0683): Reliable Epigenetic Modulation To

  2026-05-05

  This article explores real laboratory challenges in apoptosis and cell viability assays, demonstrating how 'Vorinostat (SAHA, MK0683)' (SKU A4084) from APExBIO offers reproducible, data-driven solutions. Scenario-based Q&A blocks provide actionable insights and protocol guidance for cancer biology research and epigenetic modulation workflows.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Protocol and QC Guide

  2026-05-05

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) enables specific detection of HMGB1 protein in human, mouse, and rat samples for research purposes, supporting key applications in Western blot, immunohistochemistry, and flow cytometry. It is not validated for diagnostic or therapeutic use, and its application scope should remain within chromatin protein detection workflows.

• Strategic Autophagy Inhibition: MRT68921 and ULK1/2 in Focus

  2026-05-04

  This thought-leadership article explores the mechanistic and translational value of the selective ULK1/2 inhibitor MRT68921 for autophagy research. With a synthesis of current biological understanding, evidence from recent lipid metabolism studies, and scenario-driven protocol guidance, it provides translational researchers a roadmap for leveraging MRT68921 in experimental workflows. The discussion bridges critical gaps in the competitive landscape of autophagy modulation, emphasizing quantitative assay optimization, workflow reliability, and forward-looking research opportunities.

• Applied Workflows for Recombinant Mouse M-CSF in Macrophage

  2026-05-04

  Unlock consistent macrophage activation, differentiation, and advanced disease modeling using Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag. This guide details experimentally validated workflows, troubleshooting strategies, and translational insights—empowering your bench with APExBIO's high-purity M-CSF for reliable results in immunology, fibrosis, and bone biology.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision Signal Amp

  2026-05-03

  Explore the scientific basis and advanced applications of Cy5 Goat Anti-Mouse IgG (H+L) Antibody in immunoassays. This article uniquely bridges optimized fluorescent detection with insights from hybrid vaccine research, offering a deeper assay design perspective.

• ABT-737: Precision BCL-2 Protein Inhibitor for Cancer Resear

  2026-05-02

  ABT-737 empowers researchers to induce targeted apoptosis in cancer models, leveraging its potent, selective inhibition of BCL-2 family proteins. By integrating recent mechanistic insights and optimized experimental protocols, this article delivers actionable guidance for deploying ABT-737 in hematologic malignancy and solid tumor workflows.

• Berbamine hydrochloride: Precision NF-κB Activity Inhibitor

  2026-05-01

  Berbamine hydrochloride streamlines NF-κB signaling pathway inhibition and ferroptosis modulation, empowering advanced cancer research, especially in leukemia and hepatocellular carcinoma models. This guide translates reference study insights and real-world workflows into actionable steps, troubleshooting, and protocol optimization for robust, reproducible results.

• A20 Inhibits Oxidized Self-DNA-Driven Inflammation in AKI Mo

  2026-05-01

  The reference study uncovers a critical mechanism by which the ubiquitin-editing enzyme A20 mitigates acute kidney injury (AKI) by suppressing inflammation triggered by oxidized self-DNA. This work highlights the interplay between the cGAS-STING pathway, NLRP3 inflammasome activation, and the regulatory role of A20, offering new avenues for inflammation-targeted interventions.

• Mitochondrial Permeability Transition Pore Assay Kit: Workfl

  2026-04-30

  Unlock robust mitochondrial permeability transition pore detection and quantitative analysis for cell death research with the APExBIO Mitochondrial Permeability Transition Pore Assay Kit. This article translates the latest bench findings, including those from idiopathic carpal tunnel syndrome research, into actionable workflows, troubleshooting strategies, and advanced applications.

• Advanced Biophysical Characterization of Lipid Nanoparticles

  2026-04-30

  This study presents a rigorous, multi-technique approach to characterizing lipid nanoparticles (LNPs) used for mRNA delivery, revealing substantial heterogeneity in particle size, shape, and mRNA loading. These findings have direct implications for optimizing formulations and predicting transfection efficiency in both research and clinical applications.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Pr

  2026-04-29

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe provides robust, high-contrast labeling of plasma membranes for cell migration, neuronal tracing, and membrane dynamics assessment in live and fixed specimens. It is specifically designed for lipid bilayer staining and should not be used for organelle-specific labeling or in aqueous protocols. Careful adherence to solubility and membrane compatibility parameters is essential for reproducibility.

• Chlorpromazine Hydrochloride in Antipsychotic & Hepatic Rese

  2026-04-29

  Discover how chlorpromazine hydrochloride empowers reliable dopaminergic and hepatic nanoparticle research with actionable protocols and troubleshooting strategies. Learn to optimize your workflow using APExBIO’s high-purity compound, backed by recent advances in neuropharmacology and nanomedicine.

11323 records 1/755 page Next 12345 下5页 Last page